Tepmetko

Tepmetko (tepotinib) is an oral medication used for treating certain types of non-small cell lung cancer. This targeted therapy helps manage cancer progression by inhibiting specific pathways. Suitable for patients seeking advanced treatment options.

Tepmetko (tepotinib) is primarily used to treat non-small cell lung cancer (NSCLC) in adults, particularly those with MET exon 14 skipping mutations. It is prescribed when cancer has spread locally or to other parts of the body. This medication targets specific pathways to slow or stop cancer growth. Patients may use it after other treatments have been tried.

Tepmetko works by blocking certain proteins that help cancer cells grow and spread. This targeted approach may reduce tumor size or slow its progression. Patients may experience improved symptoms related to their condition over time. Individual responses vary based on health and treatment stage.

Tepmetko should be taken exactly as prescribed by a healthcare provider. It is important to discuss all current medications, including over-the-counter and supplements, before starting treatment. Regular medical check-ups are recommended to monitor progress and manage any side effects. Avoid grapefruit or grapefruit juice while taking this medication.

Tepmetko may interact with other medications that affect liver enzymes, such as strong CYP3A inhibitors or inducers. Combining it with certain drugs could alter its effectiveness or increase side effects. Always inform your doctor about all medications you are taking. Alcohol use should be discussed with a healthcare provider.